Search results
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 6 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 11 hours agojumped more than 270% Thursday after the company said its experimental cancer drug outperformed ...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 2 days agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
Zacks via Yahoo Finance· 15 hours agoMerck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 3 days agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 2 days agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Is Merck & Co., Inc.'s (NYSE:MRK) Recent Performance Underpinned By Weak Financials?
Simply Wall St. via Yahoo Finance· 3 days agoThe investor should try to establish if the expected growth or decline in earnings, whichever the...
Merck to buy EyeBio in a deal that could valued at up to $3 billion
Morningstar· 2 days agoMerck & Co. Inc. (MRK) announced Wednesday an agreement to buy privately held Eyebiotech Ltd., an ophthalmology-focused biotechnology ...
MRK stock rated a Sell by Societe Generale – Knox Daily
Knox Daily· 3 days agoIt rated MRK as “an Outperform” which previously was an “a Market perform”. Price Performance Review of MRK On Friday, Merck & Co Inc ...
Merck Announces Third-Quarter 2024 Dividend
Morningstar· 3 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of ...
